Skye Bioscience (SKYE) Interest & Investment Income (2012 - 2026)
Skye Bioscience (SKYE) posted Interest & Investment Income of $103,208 for Q2 2026, down 80.6% from $533,090 a year earlier and down 39.2% from the prior quarter.
Powered by 
Analysis
Skye Bioscience (SKYE) Interest & Investment Income (2012 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Skye Bioscience was $965,393, down 65.4% year-over-year; for FY2025, it came in at $1.88 million, down 37.8% from FY2024.
- Annual Interest & Investment Income shows a five-year compound annual growth rate of 817.3% (FY2020 to FY2025).
- In prior years, Skye Bioscience's Interest & Investment Income was $3.03 million in FY2024, $99,974 in FY2023 (+425.9%), $19,011 in FY2022 and $3.00 in FY2021 (-89.7%).
- The Q2 2026 figure stands as the lowest quarterly Interest & Investment Income since Q4 2023.
- On a year-over-year basis, Interest & Investment Income has declined in each of the last five quarters, with an average decline of 44.9% over the last six quarters.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $169,615 (Q1 2026), $274,096 (Q4 2025) and $418,474 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Skye Bioscience | 7.38 Mn | 7.38 Mn | - | 103,208.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 103,208.00 |
| Mar 31, 2026 | 169,615.00 |
| Dec 31, 2025 | 274,096.00 |
| Sep 30, 2025 | 418,474.00 |
| Jun 30, 2025 | 533,090.00 |
| Mar 31, 2025 | 619,054.00 |
| Dec 31, 2024 | 732,274.00 |
| Sep 30, 2024 | 907,697.00 |
| Jun 30, 2024 | 961,237.00 |
| Mar 31, 2024 | 427,554.00 |
| Dec 31, 2023 | 50,305.00 |
| Sep 30, 2023 | 16,562.00 |
| Jun 30, 2023 | 8,598.00 |
| Mar 31, 2023 | 24,514.00 |
| Dec 31, 2022 | 19,011.00 |
| Dec 31, 2018 | 10.00 |
| Jun 30, 2018 | 74.00 |
| Apr 30, 2014 | 224.00 |
| Oct 31, 2013 | 391.00 |
| Jul 31, 2013 | 94.00 |
API Access
Skye Bioscience Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();